Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/77067
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Thara Tunthanathip | en_US |
dc.contributor.author | Sanguansin Ratanalert | en_US |
dc.contributor.author | Sakchai Sae-Heng | en_US |
dc.contributor.author | Thakul Oearsakul | en_US |
dc.contributor.author | Ittichai Sakarunchai | en_US |
dc.contributor.author | Anukoon Kaewborisutsakul | en_US |
dc.contributor.author | Thirachit Chotsampancharoen | en_US |
dc.contributor.author | Utcharee Intusoma | en_US |
dc.contributor.author | Amnat Kitkhuandee | en_US |
dc.contributor.author | Tanat Vaniyapong | en_US |
dc.date.accessioned | 2022-10-16T07:22:17Z | - |
dc.date.available | 2022-10-16T07:22:17Z | - |
dc.date.issued | 2021-07-01 | en_US |
dc.identifier.issn | 19984138 | en_US |
dc.identifier.issn | 09731482 | en_US |
dc.identifier.other | 2-s2.0-85115728748 | en_US |
dc.identifier.other | 10.4103/jcrt.JCRT_233_19 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85115728748&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/77067 | - |
dc.description.abstract | Background: Genomic-based tools have been used to predict poor prognosis high-grade glioma (HGG). As genetic technologies are not generally available in countries with limited resources, clinical parameters may be still necessary to use in predicting the prognosis of the disease. This study aimed to identify prognostic factors associated with survival of patients with HGG. We also proposed a validated nomogram using clinical parameters to predict the survival of patients with HGG. Methods: A multicenter retrospective study was conducted in patients who were diagnosed with anaplastic astrocytoma (WHO III) or glioblastoma (WHO IV). Collected data included clinical characteristics, neuroimaging findings, treatment, and outcomes. Prognostic factor analysis was conducted using Cox proportional hazard regression analysis. Then, we used the significant prognostic factors to develop a nomogram. A split validation of nomogram was performed. Twenty percent of the dataset was used to test the performance of the developed nomogram. Results: Data from 171 patients with HGG were analyzed. Overall median survival was 12 months (interquartile range: 5). Significant independent predictors included frontal HGG (hazard ratio [HR]: 0.62; 95% confidence interval [CI]: 0.40–0.60), cerebellar HGG (HR: 4.67; 95% CI: 0.93–23.5), (HR: 1.55; 95% CI: 1.03–2.32; reference = total resection), and postoperative radiotherapy (HR: 0.18; 95% CI: 0.10–0.32). The proposed nomogram was validated using nomogram’s predicted 1-year mortality rate. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and area under the curve of our nomogram were 1.0, 0.50, 0.45, 1.0, 0.64, and 0.75, respectively. Conclusion: We developed a nomogram for individually predicting the prognosis of HGG. This nomogram had acceptable performances with high sensitivity for predicting 1-year mortality. | en_US |
dc.subject | Medicine | en_US |
dc.title | Prognostic factors and clinical nomogram predicting survival in high-grade glioma | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Journal of Cancer Research and Therapeutics | en_US |
article.volume | 17 | en_US |
article.stream.affiliations | School of Medicine, Mae Fah Luang University | en_US |
article.stream.affiliations | Faculty of Medicine, Khon Kaen University | en_US |
article.stream.affiliations | Faculty of Medicine, Prince of Songkia University | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.